Kidney Cancer Treatment Drugs

These drugs enter your blood and reach nearly all areas of the body which makes this treatment potentially useful for cancer that has spread metastasized to organs beyond the kidney.

Kidney cancer treatment drugs. Kidney cancer treatment usually begins with surgery to remove the cancer. If the cancer has spread beyond the kidney additional treatments may be recommended. These drugs show promise in treating kidney cancer that has spread to other areas of the body. Doctors at nyu langone may prescribe a variety of medications to treat kidney cancer.

Together you and your treatment team can discuss your kidney cancer treatment options. Recent breakthroughs in kidney cancer treatments include the immunotherapy drugs ipilimumab and nivolumab. For cancers confined to the kidney this may be the only treatment needed. Nyu langone is one of the only medical centers in the new york area to use high dose immunotherapy.

Afinitor everolimus afinitor disperz everolimus aldesleukin. This material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment. Chemotherapy chemo uses anti cancer drugs that are given into a vein iv or taken by mouth as pills. The targeted drugs cabozantinib cabometyx axitinib inlyta bevacizumab avastin pazopanib votrient sorafenib nexavar and sunitinib sutent block signals that play a role in the growth of blood vessels that nourish cancer cells and allow them to spread.

If your tumor is less than 1 5 inches your doctor might suggest watchful waiting sometimes called active surveillance this. Targeted drugs used to treat advanced kidney cancer sunitinib sutent sorafenib nexavar pazopanib votrient cabozantinib cabometyx lenvatinib lenvima bevacizumab avastin axitinib inlyta temsirolimus torisel everolimus afinitor. Drugs approved for kidney renal cell cancer. Investigational drugs might be considered for certain eligible patients if other approved options have already been tried or if there is an investigational combination treatment of two approved drugs for kidney cancer.